Key Insights

Highlights

Success Rate

74% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.8%

5 terminated out of 74 trials

Success Rate

73.7%

-12.8% vs benchmark

Late-Stage Pipeline

11%

8 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed with results

Key Signals

3 with results74% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (21)
Early P 1 (3)
P 1 (1)
P 2 (2)
P 3 (4)
P 4 (4)

Trial Status

Recruiting28
Completed14
Unknown13
Enrolling By Invitation6
Not Yet Recruiting6
Terminated5

Trial Success Rate

73.7%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (74)

Showing 20 of 20 trials
NCT07567508Not ApplicableNot Yet Recruiting

Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

NCT07560306Phase 3RecruitingPrimary

[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy

NCT06788535Phase 3CompletedPrimary

REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

NCT07538518Not Yet Recruiting

PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

NCT06427304RecruitingPrimary

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

NCT07308704Recruiting

A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

NCT07529860Not ApplicableNot Yet RecruitingPrimary

AI-based Echocardiography for Detection of Cardiac Amyloidosis

NCT04862273Completed

CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis

NCT06790394Phase 1RecruitingPrimary

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

NCT05619302Phase 3CompletedPrimary

Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

NCT07435168Not ApplicableRecruitingPrimary

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

NCT07238426Enrolling By InvitationPrimary

ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, Turkey

NCT05557162Not ApplicableCompletedPrimary

Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

NCT07413081Not ApplicableNot Yet RecruitingPrimary

Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis

NCT04661800Not ApplicableCompleted

Study of Olfactory Disorders in Patients With Cardiac Amyloidosis

NCT07336394Recruiting

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

NCT04856267Completed

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders

NCT06197165Not ApplicableRecruitingPrimary

Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients

NCT06469372Not ApplicableCompletedPrimary

Cardiac Amyloidosis Discovery Trial

NCT05184088Phase 3RecruitingPrimary

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Scroll to load more

Research Network

Activity Timeline